Bristol-Myers Squibb HOME|CONTACT US|INDEX
Go Search
  • Our Company
    • Our Mission & Commitment
    • Key Facts
    • Leadership
    • Governance
    • History
    • Compliance & Ethics
    • Diversity & Inclusion
    • Our Websites
    • Achievements
    • Business Information
  • R&D
    • R&D Strategy
    • In the Pipeline
    • Investigational Compound News
    • Disease Areas of Focus
    • Our R&D
    • Our Science
    • R&D Highlights
    • Major R&D Facilities
    • Clinical Trials
    • Investigator- Sponsored Research
  • Products
    • Help Paying For Your Medicine
    • Counterfeit Drugs
    • Medical Information Inquiries
  • News
    • Press Releases
    • Publications
    • Media Library
    • Key Facts
    • Leadership
    • Financial Reporting
    • Features
    • Achievements
    • Media Contacts
    • Subscribe to e-mail alerts
  • Investors
    • Key Facts
    • Stock Information
    • SEC Filings
    • Financial Reporting
    • Events & Presentations
    • Shareholder Services
    • Investor Contacts
  • Partnering
    • Why Partner With Us?
    • Areas of Interest
    • Our Process
    • Our Partners
    • Partnering News
    • Partnering Contact
  • Responsibility
    • Bristol-Myers Squibb Foundation
    • Sustainability
    • Help Paying For Your Medicine
    • Building Our Communities
    • Grants & Giving
    • Position on Key Issues
    • Transparency
    • Clinical Trials
    • Combating Counterfeit Drugs
    • Disaster Relief & Product Donations
    • Achievements
    • Access to Medicines
  • Careers
    • Job Opportunities
    • Our Culture
    • Diversity & Inclusion
    • Developing Our People
    • University Recruitment
    • Achievements
    • Benefits
    • Apply Now
  • Products
  • Help Paying For Your Medicine
    • Help for Insured Patients
    • Help with Out-of-Pocket Costs
      • BARACLUDE® (entecavir)
      • ERBITUX® (cetuximab)
      • IXEMPRA® (ixabepilone)
      • KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release)
      • NULOJIX® (belatacept)
      • ONGLYZA® (saxagliptin)
      • ORENCIA® (abatacept)
      • REYATAZ® (atazanavir sulfate)
      • SPRYCEL® (dasatinib)
      • SUSTIVA® (efavirenz)
      • YERVOY™ (ipilimumab)
    • Help for Uninsured Patients
  • Counterfeit Drugs
  • Medical Information Inquiries
    BMS.com Home » Products » Help Paying For Your Medicine » Help with Out-of-Pocket Costs
Help with Out-of-Pocket Costs

We may be able to help insured patients pay their out-of-pocket costs for prescribed Bristol-Myers Squibb medicines.

Medicine of Interest:

  • BARACLUDE® (entecavir)
  • ERBITUX® (cetuximab)
  • IXEMPRA® (ixabepilone)
  • KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release)
  • NULOJIX® (belatacept)
  • ONGLYZA® (saxagliptin)
  • ORENCIA® (abatacept)
  • REYATAZ® (atazanavir sulfate)
  • SPRYCEL® (dasatinib)
  • SUSTIVA® (efavirenz)
  • YERVOY™ (ipilimumab)

Please click on the product links to see the Full Prescribing Information including Boxed WARNINGS for BARACLUDE® and NULOJIX®, Boxed WARNING for YERVOY™ regarding immune-mediated adverse reactions, and Boxed WARNINGS for ERBITUX® regarding infusion reactions and cardiopulmonary arrest.

 
 

© 2012 Bristol-Myers Squibb
Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy.